Paratek Pharmaceuticals Inc Banner Image

Paratek Pharmaceuticals Inc

  • Ticker PRTK
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Paratek Pharmaceuticals Inc Logo Image
  • 11-50 Employees
  • Based in Boston, Massachusetts
Paratek Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of antibacterial therapeutics based upon tetracycline chemistry in the United States. Its lead product candidate, omadacycline, is a tetracycline-derived and broad-spectrum antibiotic developed in oral tablet and intravenous formulations for use as a monotherapy antibiotic for acuteMore bacterial skin and skin structure infections (ABSSSI), community-acquired bacterial pneumonia (CABP), urinary tract infections, and other serious community-acquired bacterial infections.
4.8 / 5.0 (193)

Paratek Pharmaceuticals Inc reports have an aggregate usefulness score of 4.8 based on 193 reviews.

Paratek Pharmaceuticals Inc

Most Recent Annual Report

Paratek Pharmaceuticals Inc
MOST RECENT 2022 Annual Report and Form 10K

Paratek Pharmaceuticals Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Paratek Pharmaceuticals Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!